1,111 results on '"Neoplasms, Cystic, Mucinous, and Serous"'
Search Results
2. Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
3. Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection (MCN_Tam)
4. The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
5. Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts
6. Genetics of Appendix Cancer Study (GAP)
7. Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer (MAPS)
8. Early Detection of Pancreatic Cystic Neoplasms
9. Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas
10. Intra-operative Pancreatoscopy in Patients With IPMN
11. DCE MRI in Patients With Pancreatic Cancer
12. High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
13. Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
14. Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
15. Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia. (RESCUE)
16. Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI) (ESPRIT-AI)
17. UCSF PANC Cyst Registry (UCSF PCR)
18. Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
19. Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
20. A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm
21. Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement: A Prospective Observational Study.
22. Establishment of Abbreviated Pancreatobiliary MRI Protocol
23. Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts
24. Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms
25. External validation of a machine learning based algorithm to differentiate hepatic mucinous cystic neoplasms from benign hepatic cysts.
26. Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
27. Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
28. Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)
29. Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
30. Study of Risk Factors for Intraductal Papillary Mucinous Neoplasms Degeneration at the Nancy CHRU (IPMN) (IPMN)
31. SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications
32. 18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study
33. A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas (CONCYST)
34. Reliability of the Preoperative Work-up in Patients Submitted to Surgery for Cystic Neoplasms of the Pancreas (NCP-1)
35. Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome
36. Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Small Benign Pancreatic Tumors
37. Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy
38. Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB) (WESIPNB)
39. Low Rectal Cancer Study (MERCURY II) (MERCURY II)
40. Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
41. Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (MARVEL)
42. Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor
43. Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms
44. Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions (CINE-Cyst)
45. Natural history and growth prediction model of pancreatic serous cystic neoplasms.
46. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study.
47. ASO Author Reflections: The Role of Neoadjuvant Chemotherapy in Invasive Intraductal Mucinous Neoplasms of the Pancreas.
48. Recurrent GATA3 P409Afs*99 Frameshift Extension Mutations in Sweat-gland Carcinoma With Neuroendocrine Differentiation.
49. Pseudomyxoma peritonei originating from low grade mucinous neoplasm of the urachus.
50. Low-Grade Mucinous Neoplasm Arising in an Enteric Duplication Cyst of Pancreas: A Case Report and Literature Review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.